(Q54038587)

24 May 2018

title

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. (English)

1 reference

24 May 2018

0 references

3

1 reference

24 May 2018

author name string

A P Limaye

1

1 reference

24 May 2018

L Corey

2

1 reference

24 May 2018

C L Davis

4

1 reference

24 May 2018

M Boeckh

5

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

24 May 2018

published in

The Lancet

1 reference

24 May 2018

volume

356

1 reference

24 May 2018

issue

9230

1 reference

24 May 2018

page(s)

645-649

1 reference

24 May 2018

Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Treatment of gancyclovir resistant cytomegalovirus with foscarnet: a report of two cases occurring after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Cytomegalovirus: the taming of the beast?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Factors influencing detection of quantitative cytomegalovirus antigenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Interrelationships among Quantity of Human Cytomegalovirus (HCMV) DNA in Blood, Donor‐Recipient Serostatus, and Administration of Methylprednisolone as Risk Factors for HCMV Disease following Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Quantitation of human cytomegalovirus DNA in peripheral blood leukocytes of heart transplant recipients: relationship with pp65 antigenemia and with antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902607-6

7 January 2021

10.1016/S0140-6736(00)02607-6

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10968438

1 reference

24 May 2018